Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions. 1983

P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry

Compatibility and stability of labetalol hydrochloride when mixed with commonly used large-volume parenterals (LVPs) were tested. Labetalol hydrochloride injection was added to 11 LVPs at concentrations of 1.25, 2.50, and 3.75 mg/ml. After initial samples were obtained, the admixtures were divided equally and stored for 72 hours at 4 degrees C and 25 degrees C. The initial samples and aliquots withdrawn at 6, 24, and 72 hours were frozen until analysis. The initial and 72-hour samples were analyzed for drug concentration, pH, osmolarity, and visual changes. High-performance liquid chromatography (HPLC) was used for the assay, and the American Public Health Association color-testing procedure was used in evaluating color. In the admixture with 5% sodium bicarbonate injection, a white precipitate formed within six hours. At both storage temperatures, the drug concentration in all other LVP solutions was not appreciably different from the initial concentration. No additional HPLC peaks were noted, and no measurable change in pH or osmolarity occurred. No haze, precipitate, or color change occurred in the 10 admixtures. Labetalol hydrochloride was stable for 72 hours at 4 degrees C and 25 degrees C in all i.v. solutions studied except 5% sodium bicarbonate injection.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003116 Color The visually perceived property of objects created by absorption or reflection of specific wavelengths of light. Colors
D004344 Drug Incompatibility The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed) Drug Incompatibilities,Incompatibilities, Drug,Incompatibility, Drug
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution

Related Publications

P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
November 1986, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
June 1993, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
October 1989, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
June 1976, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
January 1987, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
January 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
April 1993, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
July 1983, American journal of hospital pharmacy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
May 1996, The Annals of pharmacotherapy,
P H Yuen, and C R Taddei, and B E Wyka, and I A Chaudry
August 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Copied contents to your clipboard!